96 related articles for article (PubMed ID: 8573009)
1. Evaluation of the antithrombogenicity of a new microdomain structured copolymer.
Kawahito K; Tasai K; Murata S; Yamaguchi A; Mizuhara A; Adachi H; Ino T
Artif Organs; 1995 Aug; 19(8):857-63. PubMed ID: 8573009
[TBL] [Abstract][Full Text] [Related]
2. [A clinical and experimental study of the antithrombotic percutaneous cardiopulmonary support using the new antithrombotic coating material].
Kawahito K
Nihon Kyobu Geka Gakkai Zasshi; 1993 Sep; 41(9):1467-77. PubMed ID: 8409600
[TBL] [Abstract][Full Text] [Related]
3. In vivo evaluation of a fluorine-acryl-stylene-urethane-silicone antithrombogenic coating material copolymer for intravascular stents.
Matsuhashi T; Miyachi H; Ishibashi T; Sakamoto K; Yamadera A
Acad Radiol; 1996 Jul; 3(7):581-8. PubMed ID: 8796720
[TBL] [Abstract][Full Text] [Related]
4. [In vivo evaluation of the new antithrombogenic reservoir-catheter coated with polymer blend copolymer].
Matsumoto S; Yamada Y; Kiyosue H; Dono S; Mori H; Imagawa M; Nomura Y; Toyoda H; Shimada T
Nihon Igaku Hoshasen Gakkai Zasshi; 1997 Apr; 57(5):238-43. PubMed ID: 9164111
[TBL] [Abstract][Full Text] [Related]
5. Experimental thrombosis on a collagen coated arterioarterial shunt in rats: a pharmacological model to study antithrombotic agents inhibiting thrombin formation and platelet deposition.
Freund M; Mantz F; Nicolini P; Gachet C; Mulvihill J; Meyer L; Beretz A; Cazenave JP
Thromb Haemost; 1993 May; 69(5):515-21. PubMed ID: 8322274
[TBL] [Abstract][Full Text] [Related]
6. Hydrophilic-hydrophobic microdomain surfaces having an ability to suppress platelet aggregation and their in vitro antithrombogenicity.
Okano T; Aoyagi T; Kataoka K; Abe K; Sakurai Y; Shimada M; Shinohara I
J Biomed Mater Res; 1986 Sep; 20(7):919-27. PubMed ID: 3760008
[TBL] [Abstract][Full Text] [Related]
7. Incorporating Anticoagulant and Antiplatelet Dual Functional Groups into Thermosetting Polymer Chain for Enhancing Antithrombogenicity.
Wang W; Liu S; Zhang S; Zhang J; Tang Y; Zhang W
Adv Healthc Mater; 2023 Oct; 12(26):e2300680. PubMed ID: 37515824
[TBL] [Abstract][Full Text] [Related]
8. In vitro and in vivo studies on antithrombogenicity of poly(propylene oxide) segmented nylon 610 in relation to its crystalline-amorphous microstructure.
Yui N; Kataoka K; Sakurai Y; Aoki T; Sanui K; Ogata N
Biomaterials; 1988 May; 9(3):225-9. PubMed ID: 3408792
[TBL] [Abstract][Full Text] [Related]
9. Antithrombotic activity of Z4A5, a new platelet glycoprotein IIb/IIIa receptor antagonist evaluated in a rabbit arteriovenous shunt thrombosis model.
Jing BB; Li YX; Zhang H; Ren ST; Wang M; Li YP; Zang WJ; Wang B
Thromb Res; 2011 Nov; 128(5):463-9. PubMed ID: 21924458
[TBL] [Abstract][Full Text] [Related]
10. Suppression mechanisms for thrombus formation on heparin-immobilized segmented polyurethane-ureas.
Nojiri C; Okano T; Park KD; Kim SW
ASAIO Trans; 1988; 34(3):386-98. PubMed ID: 3196537
[TBL] [Abstract][Full Text] [Related]
11. Effects of GP IIb/IIIa receptor monoclonal antibody (7E3), heparin, and aspirin in an ex vivo canine arteriovenous shunt model of stent thrombosis.
Makkar RR; Litvack F; Eigler NL; Nakamura M; Ivey PA; Forrester JS; Shah PK; Jordan RE; Kaul S
Circulation; 1997 Feb; 95(4):1015-21. PubMed ID: 9054765
[TBL] [Abstract][Full Text] [Related]
12. Negative cilia concept for thromboresistance: synergistic effect of PEO and sulfonate groups grafted onto polyurethanes.
Han DK; Jeong SY; Kim YH; Min BG; Cho HI
J Biomed Mater Res; 1991 May; 25(5):561-75. PubMed ID: 1869574
[TBL] [Abstract][Full Text] [Related]
13. Comparison of enoxaparin, hirulog, and heparin as adjunctive antithrombotic therapy during thrombolysis with rtPA in the stenosed canine coronary artery.
Leadley RJ; Kasiewski CJ; Bostwick JS; Bentley R; McVey MJ; White FJ; Perrone MH; Dunwiddie CT
Thromb Haemost; 1997 Oct; 78(4):1278-85. PubMed ID: 9364998
[TBL] [Abstract][Full Text] [Related]
14. Platelet deposition onto polymeric surfaces during shunting.
Fujimoto K; Minato M; Tadokoro H; Ikada Y
J Biomed Mater Res; 1993 Mar; 27(3):335-43. PubMed ID: 8360203
[TBL] [Abstract][Full Text] [Related]
15. [A clinical experience of V-A bypass using a new antithrombotic coating material].
Kawahito K; Ino T; Ide H; Adachi H; Mizuhara A; Yamaguchi A
Nihon Kyobu Geka Gakkai Zasshi; 1992 Jul; 40(7):1110-5. PubMed ID: 1506705
[TBL] [Abstract][Full Text] [Related]
16. [Effect of hydrogen sulfide on tissue factor-induced disseminated intravascular coagulation in rabbits].
Lu X; Li W; Wang G; Wang Q; Jiang Y; Gao J; Zhao X; Xu L
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2015 Feb; 27(2):92-6. PubMed ID: 25665605
[TBL] [Abstract][Full Text] [Related]
17. In vivo inhibition of acute platelet-dependent thrombosis in a baboon model by Bay U3405, a thromboxane A2-receptor antagonist.
Kotzé HF; Lamprecht S; Badenhorst PN; van Wyk V; Roodt JP; Alexander K
Thromb Haemost; 1993 Oct; 70(4):672-5. PubMed ID: 8115994
[TBL] [Abstract][Full Text] [Related]
18. Pneumatic tube system transport does not alter platelet function in optical and whole blood aggregometry, prothrombin time, activated partial thromboplastin time, platelet count and fibrinogen in patients on anti-platelet drug therapy.
Enko D; Mangge H; Münch A; Niedrist T; Mahla E; Metzler H; Prüller F
Biochem Med (Zagreb); 2017 Feb; 27(1):217-224. PubMed ID: 28392742
[TBL] [Abstract][Full Text] [Related]
19. Acute Thrombogenicity of a Durable Polymer Everolimus-Eluting Stent Relative to Contemporary Drug-Eluting Stents With Biodegradable Polymer Coatings Assessed Ex Vivo in a Swine Shunt Model.
Otsuka F; Cheng Q; Yahagi K; Acampado E; Sheehy A; Yazdani SK; Sakakura K; Euller K; Perkins LEL; Kolodgie FD; Virmani R; Joner M
JACC Cardiovasc Interv; 2015 Aug; 8(9):1248-1260. PubMed ID: 26292590
[TBL] [Abstract][Full Text] [Related]
20. Antiplatelet and antithrombotic activities of timosaponin B-II, an extract of Anemarrhena asphodeloides.
Lu WQ; Qiu Y; Li TJ; Tao X; Sun LN; Chen WS
Clin Exp Pharmacol Physiol; 2011 Jul; 38(7):430-4. PubMed ID: 21517935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
